Pharming Group's market cap is currently ―. The company's EPS TTM is $-0.154; its P/E ratio is -65.70; Pharming Group is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is

lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	€ 54.24M	€ 50.15M	€ 46.62M
Gross Profit	-	-	€ 51.85M	€ 46.12M	€ 41.74M
EBIT	-	-	€ 10.53M	€ 20.91M	€ 5.61M
EBITDA	-	-	€ 12.48M	€ 22.98M	€ 7.80M
Net Income Common Stockholders	-	-	€ 9.10M	€ 15.74M	€ 3.46M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 213.42M	€ 2.90M	€ 188.70M	€ 189.96M	€ 189.67M
Total Assets	€ 462.85M	€ 425.80M	€ 382.32M	€ 393.90M	€ 392.80M
Total Debt	€ 171.54M	€ 166.69M	€ 139.18M	€ 149.00M	€ 157.79M
Net Debt	€ -41.88M	€ 163.79M	€ -49.52M	€ -40.96M	€ -31.89M
Total Liabilities	€ 244.07M	€ 242.90M	€ 182.07M	€ 194.23M	€ 198.78M
Stockholders Equity	€ 218.78M	€ 205.87M	€ 200.25M	€ 199.67M	€ 194.02M
Cash Flow	-
Free Cash Flow	-	-	€ 12.51M	€ 2.81M	€ 234.00K
Operating Cash Flow	-	-	€ 12.62M	€ 4.00M	€ 609.00K
Investing Cash Flow	-	-	€ -298.00K	€ 6.39M	€ -374.00K
Financing Cash Flow	-	-	€ -1.92M	€ -451.00K	€ -2.89M

Currency in EUR

Pharming Group Earnings and Revenue History

Income Statement >

Pharming Group Debt to Assets

Balance Sheet >

Pharming Group Cash Flow

Cash Flow >

Pharming Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing